The common virus’ link with multiple sclerosis is likely to be caused by greater amounts of immune system ‘misdirection’ than previously thought
Birmingham researchers are using cutting edge organ-on-a-chip technology to improve immunotherapy for liver cancer.
People with chronic inflammatory diseases are taking part in a new cell therapy clinical trial that one participant said made them feel “miles better”.
The research focused on a protein involved in liver inflammation and fibrosis.
The UK government has awarded BactiVac, £700k to accelerate the development of bacterial vaccines with a focus on pathogens with epidemic outbreak potential.
A world-class Allergy, Asthma and Clinical Immunology Center in Birmingham has successfully had their center status renewed.
As AMR threatens to become the leading cause of death by 2050, vaccines could lead way to tackle drug-resistant infections and reduce reliance on antibiotics
Birmingham researchers hosted a unique event that brought together liver disease patients, researchers, charity partners, and an artist in residence.
The network includes the Midlands-Wales Advanced Therapy Treatment Centre, jointly delivered by University of Birmingham and University Hospitals Birmingham.
University of Birmingham and NHS England researchers have created a diagnostic code for presymptomatic type 1 diabetes to enhance healthcare treatment.
Professor Gary Middleton, Professor of Oncology, will be at the forefront of pioneering cancer research as ECMC Network Lead.
97% of patients who were deemed low risk and took part were assessed as not having allergy